Alessandro Fichera

Hans Herfarth is Director of the Multidisciplinary IBD Center at the University of North Carolina. His primary research interests focus on the development and evaluation of novel diagnostic and therapeutic approaches for patients with inflammatory bowel diseases (IBD). His work is particularly centered on the conceptualization and conduct of investigator-initiated clinical studies in IBD, supported by funding from the NIH, the Crohn’s & Colitis Foundation, and private and industry-associated foundations. Dr. Herfarth has authored more than 350 journal articles, book chapters, and review articles related to IBD.

Laura Raffals, MD, MS, FACG is Professor of Medicine, Vice Chair, Department of Medicine at Mayo Clinic, Rochester, MN. She received her Masters in Health Studies and completed her gastroenterology fellowship training at the University of Chicago, and for six years was a member of the faculty. In 2011, she joined the Gastroenterology and Hepatology Division at Mayo Clinic. Dr. Raffals’ clinical and research interests have focused on inflammatory bowel disease with a focus on pouch disorders, exploring the intersection of pouch motility disorders and pouch inflammation. She is the co-principal investigator for the Crohn’s and Colitis Foundation SPARC IBD, a national prospective adult research cohort with IBD study and has published broadly on topics in inflammatory bowel disease.

Bincy P. Abraham, M.D., M.S., AGAF, FACG, FASGE, FCCF is the Distinguished Professor and Director of the Fondren Inflammatory Bowel Disease Program at the Underwood Digestive Diseases Center of Houston Methodist Hospital. She is also the Program Director for the Gastroenterology Fellowship and Associate Program Director of the Advanced IBD Fellowship at Houston Methodist Hospital. She earned her medical degree from University of Texas Medical Branch, Galveston, TX, where she continued with residency training in internal medicine and fellowship in gastroenterology. During fellowship, she received specialized training in inflammatory bowel disease and earned her degree in Masters of Clinical Investigation. She also completed a National Visiting Fellow Inflammatory Bowel Disease Rotation program through the Crohn’s and Colitis Foundation in Cedars Sinai Hospital in Los Angeles. She has chaired the Southern Regional chapter of the CCFA Medical Advisory Committee, served as president of the Texas Gulf Coast Gastroenterology Society, is involved in national committees for and is a Fellow of the American College of Gastroenterology, American Gastroenterology Association, American Society of Gastrointestinal Endoscopy, and Crohn's and Colitis Foundation. She is trained in and passionate about intestinal ultrasound in IBD patient care.

Edward L. Barnes, MD, MPH is an Associate Professor of Medicine in the Division of Gastroenterology & Hepatology and Co-Director of the Multidisciplinary Inflammatory Bowel Diseases Center at the University of North Carolina of Chapel Hill. Dr. Barnes received his undergraduate and medical degrees from the University of South Carolina. He completed his internship, residency, and chief residency in internal medicine at the University of North Carolina. He completed his gastroenterology fellowship at Brigham and Women’s Hospital in Boston, Massachusetts. During his gastroenterology fellowship, Dr. Barnes received a Master of Public Health from the Harvard TH Chan School of Public Health. Following his gastroenterology fellowship, Dr. Barnes completed a one year advanced fellowship in inflammatory bowel disease at the University of North Carolina.

Dr. Barnes has a research interest in the epidemiology and clinical outcomes of patients with inflammatory bowel disease. He has a particular interest in improving our understanding of inflammatory conditions of the pouch after restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA). He has received funding from the National Institutes of Health, Crohn’s & Colitis Foundation, American College of Gastroenterology, and American Gastroenterological Association to study clinical outcomes of patients with pouchitis and other pouch-related conditions and to investigate predictors of a complicated disease course after IPAA. Dr. Barnes is the 2021 Sherman Emerging Leader Prize recipient.

Dr. Fichera earned his M.D. from the Catholic University of Rome, completed General Surgery Residency at the University of Chicago and two year fellowship in laparoscopic and colorectal surgery at Mt. Sinai School of Medicine in New York. He returned to the University of Chicago where he started and became the first Program Director of the Colon and Rectal Surgery Training Program. He moved to the University of Washington in July 2012 as chief of colorectal surgery and was appointed chief of the section of Gastrointestinal Surgery in 2014 and in 2016 the clinical director of Gastrointestinal Oncology at the Seattle Cancer Care Alliance. In November 2017 he moved to University of North Carolina as the Division Chief of Gastrointestinal Surgery. In September 2019 he became the Division Chief of Colorectal Surgery at Baylor University Medical Center in Dallas, Texas and the Surgery Safety and Quality Officer since July 2020. His clinical and research interest include colorectal cancer and inflammatory bowel disease

Hans Herfarth is Director of the Multidisciplinary IBD Center at the University of North Carolina. His primary research interests focus on the development and evaluation of novel diagnostic and therapeutic approaches for patients with inflammatory bowel diseases (IBD). His work is particularly centered on the conceptualization and conduct of investigator-initiated clinical studies in IBD, supported by funding from the NIH, the Crohn’s & Colitis Foundation, and private and industry-associated foundations. Dr. Herfarth has authored more than 350 journal articles, book chapters, and review articles related to IBD.

Laura Raffals, MD, MS, FACG is Professor of Medicine, Vice Chair, Department of Medicine at Mayo Clinic, Rochester, MN. She received her Masters in Health Studies and completed her gastroenterology fellowship training at the University of Chicago, and for six years was a member of the faculty. In 2011, she joined the Gastroenterology and Hepatology Division at Mayo Clinic. Dr. Raffals’ clinical and research interests have focused on inflammatory bowel disease with a focus on pouch disorders, exploring the intersection of pouch motility disorders and pouch inflammation. She is the co-principal investigator for the Crohn’s and Colitis Foundation SPARC IBD, a national prospective adult research cohort with IBD study and has published broadly on topics in inflammatory bowel disease.

Bincy P. Abraham, M.D., M.S., AGAF, FACG, FASGE, FCCF is the Distinguished Professor and Director of the Fondren Inflammatory Bowel Disease Program at the Underwood Digestive Diseases Center of Houston Methodist Hospital. She is also the Program Director for the Gastroenterology Fellowship and Associate Program Director of the Advanced IBD Fellowship at Houston Methodist Hospital. She earned her medical degree from University of Texas Medical Branch, Galveston, TX, where she continued with residency training in internal medicine and fellowship in gastroenterology. During fellowship, she received specialized training in inflammatory bowel disease and earned her degree in Masters of Clinical Investigation. She also completed a National Visiting Fellow Inflammatory Bowel Disease Rotation program through the Crohn’s and Colitis Foundation in Cedars Sinai Hospital in Los Angeles. She has chaired the Southern Regional chapter of the CCFA Medical Advisory Committee, served as president of the Texas Gulf Coast Gastroenterology Society, is involved in national committees for and is a Fellow of the American College of Gastroenterology, American Gastroenterology Association, American Society of Gastrointestinal Endoscopy, and Crohn's and Colitis Foundation. She is trained in and passionate about intestinal ultrasound in IBD patient care.

Edward L. Barnes, MD, MPH is an Associate Professor of Medicine in the Division of Gastroenterology & Hepatology and Co-Director of the Multidisciplinary Inflammatory Bowel Diseases Center at the University of North Carolina of Chapel Hill. Dr. Barnes received his undergraduate and medical degrees from the University of South Carolina. He completed his internship, residency, and chief residency in internal medicine at the University of North Carolina. He completed his gastroenterology fellowship at Brigham and Women’s Hospital in Boston, Massachusetts. During his gastroenterology fellowship, Dr. Barnes received a Master of Public Health from the Harvard TH Chan School of Public Health. Following his gastroenterology fellowship, Dr. Barnes completed a one year advanced fellowship in inflammatory bowel disease at the University of North Carolina.

Dr. Barnes has a research interest in the epidemiology and clinical outcomes of patients with inflammatory bowel disease. He has a particular interest in improving our understanding of inflammatory conditions of the pouch after restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA). He has received funding from the National Institutes of Health, Crohn’s & Colitis Foundation, American College of Gastroenterology, and American Gastroenterological Association to study clinical outcomes of patients with pouchitis and other pouch-related conditions and to investigate predictors of a complicated disease course after IPAA. Dr. Barnes is the 2021 Sherman Emerging Leader Prize recipient.

Dr. Fichera earned his M.D. from the Catholic University of Rome, completed General Surgery Residency at the University of Chicago and two year fellowship in laparoscopic and colorectal surgery at Mt. Sinai School of Medicine in New York. He returned to the University of Chicago where he started and became the first Program Director of the Colon and Rectal Surgery Training Program. He moved to the University of Washington in July 2012 as chief of colorectal surgery and was appointed chief of the section of Gastrointestinal Surgery in 2014 and in 2016 the clinical director of Gastrointestinal Oncology at the Seattle Cancer Care Alliance. In November 2017 he moved to University of North Carolina as the Division Chief of Gastrointestinal Surgery. In September 2019 he became the Division Chief of Colorectal Surgery at Baylor University Medical Center in Dallas, Texas and the Surgery Safety and Quality Officer since July 2020. His clinical and research interest include colorectal cancer and inflammatory bowel disease

Maria T. Abreu, MD, is a physician-scientist and gastroenterologist who specializes in inflammatory bowel diseases (IBD). She received her medical degree from the University of Miami School of Medicine and completed a residency in medicine at the Brigham and Women’s Hospital. She served as an Associate Professor of Medicine at Mount Sinai School of Medicine (and head of their IBD Center), a Professor of Medicine and Microbiology & Immunology at the University of Miami School of Medicine (and Director of the Crohn’s and Colitis Center), and currently is the Executive Director of the F. Widjaja IBD Institute at Cedars-Sinai Medical Center; in past years, she has served as the President of the American Gastroenterological Association (AGA) and the Chair of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). Dr. Abreu has 30 years of leadership experience in basic, translational, and clinical research, and has authored almost 300 peer-reviewed articles, book chapters, and reviews. Her work has received multiple awards, including the 2019 Sherman Prize from the Bruce and Cynthia Sherman Charitable Foundation for outstanding achievements in IBD and Healio’s Lifetime Disruptor Award for addressing critical unmet needs in IBD. Her research focuses on interactions between the gut microbiome and the innate immune system in the development of IBD and IBD-associated colon cancer. Currently, Dr. Abreu’s team is investigating how diet may shape the gut microbiome and alleviate IBD symptoms. Understand the underlying mechanisms can help us develop targeted treatment strategies to help patients live their best lives.

Dr. Cheifetz is Director of the Center for Inflammatory Bowel Disease and Medical Director of Infusion Services at Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. He is also Director of the Harvard Medical School Gastroenterology Clerkship Elective and Associate Director of the Advanced Fellowship in Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center.
Dr. Cheifetz specializes in the treatment of Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases. In addition to his clinical work, he is involved in multiple research projects relating to IBD and has published over 250 articles and chapters on the subject. His research currently focuses on optimizing the use of biologics through the proactive use of drug concentrations and antibodies, and he has published extensively in this area. Dr. Cheifetz was the first to demonstrate that proactive monitoring of infliximab and adalimumab concentrations and dosing to a therapeutic window improves outcomes when compared to standard of care. Dr. Cheifetz lectures nationally and internationally on IBD. Dr. Cheifetz is also actively involved in teaching and mentoring medical students, residents, and fellows, and is proud to have trained numerous physicians who now specialize in IBD and direct their own centers.

Dr. Fichera earned his M.D. from the Catholic University of Rome, completed General Surgery Residency at the University of Chicago and two year fellowship in laparoscopic and colorectal surgery at Mt. Sinai School of Medicine in New York. He returned to the University of Chicago where he started and became the first Program Director of the Colon and Rectal Surgery Training Program. He moved to the University of Washington in July 2012 as chief of colorectal surgery and was appointed chief of the section of Gastrointestinal Surgery in 2014 and in 2016 the clinical director of Gastrointestinal Oncology at the Seattle Cancer Care Alliance. In November 2017 he moved to University of North Carolina as the Division Chief of Gastrointestinal Surgery. In September 2019 he became the Division Chief of Colorectal Surgery at Baylor University Medical Center in Dallas, Texas and the Surgery Safety and Quality Officer since July 2020. His clinical and research interest include colorectal cancer and inflammatory bowel disease

Kelly Issokson, MS, RD, CSDH, LDN, CNSC is the Senior Registered Dietitian of Outpatient Nutrition at the University of California, San Francisco (UCSF) and a nationally recognized expert in gastrointestinal nutrition. With over 17 years of clinical experience, she specializes in inflammatory bowel disease (IBD) and surgical nutrition. Ms. Issokson graduated magna cum laude from Johnson & Wales University and earned her MS in Nutrition from California State University, Northridge. She serves on the National Board of the Crohn’s & Colitis Foundation and is a leading voice in advancing nutrition as part of multidisciplinary IBD care. She co-developed the Cedars-Sinai IBD Prehabilitation Program and nutrition education training programs for physicians, APPs, and RDs.

Dr. Amanda Ricciuto completed her medical degree and General Paediatrics training in Montreal at McGill University. She then moved to Toronto to complete fellowship training in Paediatric Gastroenterology at SickKids, including advanced training in the management of paediatric inflammatory bowel disease (IBD). During that time, she obtained a PhD in Clinical Epidemiology and Health Care Research at the Institute of Health Policy, Management and Evaluation at the University of Toronto. Her PhD focused on IBD-associated liver disease, with an emphasis on primary sclerosing cholangitis (PSC).

Areas of Specialty
Dr. Ricciuto’s areas of specialty include paediatric inflammatory bowel disease and IBD-associated liver disease, particularly primary sclerosing cholangitis.

Research Interests
Dr. Ricciuto’s research interests include paediatric IBD generally, as well as the complex inter-relationship between IBD and primary sclerosing cholangitis. Her work has served to better delineate the phenotype of PSC-associated IBD in children and to guide monitoring strategies in this population. From a methodologic standpoint, she has expertise in longitudinal data analysis.

Corey A. Siegel, MD, MS, is the Director of the Walter and Carole Young Center for Digestive Health at the Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire. He is the Constantine and Joyce Hampers Professor of Medicine and a Professor at The Dartmouth Institute for Health Policy and Clinical Practice at the Geisel School of Medicine at Dartmouth.

Dr. Siegel received his medical degree from Tufts University School of Medicine in Boston, Massachusetts. He completed his residency in internal medicine at the Dartmouth Hitchcock Medical Center where he also served as chief medical resident. He then completed a fellowship in Gastroenterology at Dartmouth Hitchcock followed by a fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital in Boston.

Dr. Siegel’s research interests include understanding risk/benefit tradeoffs in IBD, developing models to predict outcomes in Crohn’s disease, creating tools to facilitate shared decision making, expanding telemedicine services to patients with IBD living in rural locations, and improving the quality of care delivered to patients with IBD. He has been funded by the NIH, AHRQ, the Crohn’s and Colitis Foundation, and the Leona M. and Harry B. Helmsley Charitable Trust for this work. Dr. Siegel is the founder of the BRIDGe group, an international research collaborative of IBD investigators. Dr. Siegel was inducted into the International Organization for the Study of IBD (IOIBD) in 2013 and he received the Sherman Prize in 2023. He lives in Hanover, New Hampshire with his wife and three boys.

Dr. Fichera earned his M.D. from the Catholic University of Rome, completed General Surgery Residency at the University of Chicago and two year fellowship in laparoscopic and colorectal surgery at Mt. Sinai School of Medicine in New York. He returned to the University of Chicago where he started and became the first Program Director of the Colon and Rectal Surgery Training Program. He moved to the University of Washington in July 2012 as chief of colorectal surgery and was appointed chief of the section of Gastrointestinal Surgery in 2014 and in 2016 the clinical director of Gastrointestinal Oncology at the Seattle Cancer Care Alliance. In November 2017 he moved to University of North Carolina as the Division Chief of Gastrointestinal Surgery. In September 2019 he became the Division Chief of Colorectal Surgery at Baylor University Medical Center in Dallas, Texas and the Surgery Safety and Quality Officer since July 2020. His clinical and research interest include colorectal cancer and inflammatory bowel disease

Phillip R. Fleshner, MD is the Director of Colorectal Surgery Research at Cedars-Sinai Medical Center. He holds the Shierley, Jesslyne, and Emmeline Widjaja Chair in Colorectal Surgery.

Dr. Fleshner's main clinical and research interests are directed towards optimizing outcomes and techniques in the surgical management of Crohn's disease and ulcerative colitis.

Dr. Fleshner has written numerous articles for peer-reviewed publications, including the Annals of Surgery, Journal of the American College of Surgeons, Diseases of the Colon and Rectum, Gut and the American Journal of Surgery.

Dr. Fleshner received his bachelor's degree from McGill University and his medical degree from the Albert Einstein College of Medicine. He completed his General Surgery Residency at the Mount Sinai Medical Center in New York and his Colorectal Surgery Fellowship at the Lahey Clinic in Boston.

He received the Sherman Prize in 2021.

Dr. Fichera earned his M.D. from the Catholic University of Rome, completed General Surgery Residency at the University of Chicago and two year fellowship in laparoscopic and colorectal surgery at Mt. Sinai School of Medicine in New York. He returned to the University of Chicago where he started and became the first Program Director of the Colon and Rectal Surgery Training Program. He moved to the University of Washington in July 2012 as chief of colorectal surgery and was appointed chief of the section of Gastrointestinal Surgery in 2014 and in 2016 the clinical director of Gastrointestinal Oncology at the Seattle Cancer Care Alliance. In November 2017 he moved to University of North Carolina as the Division Chief of Gastrointestinal Surgery. In September 2019 he became the Division Chief of Colorectal Surgery at Baylor University Medical Center in Dallas, Texas and the Surgery Safety and Quality Officer since July 2020. His clinical and research interest include colorectal cancer and inflammatory bowel disease